driven by the PitchBook Platform
Developer of oncology pharmaceuticals targeting pathways used by cancer cells to grow. The company is engaged in the discovery of novel, small-molecule drugs that affect protein-degradation pathways, upon which cancer cells depend for survival.
You’re viewing a free company profile from the PitchBook Platform. To explore Cleave Biosciences’s full profile, request a free trial.
5 Former Executives
3 Former Board Members
© 2018 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.